The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research. | Am J Respir Crit Care Med;208(5): 515-516, 2023 09 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research.

Dempsey, Timothy M; Limper, Andrew H.

Affiliation

Dempsey TM; David Grant Medical Center U.S. Air Force Travis Air Force Base, California.
Limper AH; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery Mayo Clinic Rochester, Minnesota.

Am J Respir Crit Care Med ; 208(5): 515-516, 2023 09 01.

Article in En | MEDLINE | ID: mdl-37499091

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2023 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2023 Document type: Article Country of publication: